Tagmotor neurone disease

An experimental drug for motor neurone disease (MND) has shown signs of slowing the progress of the devastating illness in a landmark trial. The results provide fresh hope after a phase-three trial of the same drug had previously failed to make a meaningful difference to patient outcomes after six months of treatment. The latest results suggest that when patients continued taking the Biogen drug...